3w39: Difference between revisions

Revision as of 10:48, 19 December 2012 view source OCA (talk \| contribs) Bots, Bureaucrats, journal, Administrators 3,331,097 edits m Protected "3w39" [edit=sysop:move=sysop] ← Older edit		Revision as of 08:36, 2 January 2013 view source OCA (talk \| contribs) Bots, Bureaucrats, journal, Administrators 3,331,097 edits No edit summary Newer edit →
Line 5:		Line 5:
	Authors: Yagita, Y., Kuse, N., Kuroki, K., Gatanaga, H., Carlson, J.M., Chikata, T., Brumme, Z.L., Murakoshi, H., Akahoshi, T., Pfeifer, N., Mallal, S., John, M., Ose, T., Matsubara, H., Kanda, R., Fukunaga, Y., Honda, K., Kawashima, Y., Ariumi, Y., Oka, S., Maenaka, K., Takiguchi, M.		Authors: Yagita, Y., Kuse, N., Kuroki, K., Gatanaga, H., Carlson, J.M., Chikata, T., Brumme, Z.L., Murakoshi, H., Akahoshi, T., Pfeifer, N., Mallal, S., John, M., Ose, T., Matsubara, H., Kanda, R., Fukunaga, Y., Honda, K., Kawashima, Y., Ariumi, Y., Oka, S., Maenaka, K., Takiguchi, M.

	Description: ~~CRYSTAL STRUCTURE OF~~ HLA-B*5201 ~~IN COMPLEXED WITH~~ HIV ~~IMMUNODOMINANT EPITOPE~~ (TAFTIPSI)		Description: Crystal structure of HLA-B*5201 in complexed with HIV immunodominant epitope (TAFTIPSI)

Navigation menu